Extract
Note: Please read the complete
full text with Figures and Tables at

Introduction
The contraction of cardiac myocytes in the heart is
initiated when Ca2+ enters the cell via L-type
Ca2+ channels in the sarcolemma.
Ca2+ entry then triggers the release of a much
larger amount of Ca2+ from the sarcoplasmic
reticulum (SR)[1,2]. The elementary event of the SR
Ca2+ release through ryanodine receptor type 2 (RyR2) is the
Ca2+ spark. The spontaneous Ca2+ sparks in quiescent cardiac myocytes reflect the SR
Ca2+ content, the function of RyR2, and SR
Ca2+-ATPase 2a (SERCA2a), as well as the SR
Ca2+ leak[3]. It is the
synchronized activation of many Ca2+ sparks triggered by
Ca2+ entry via L-type Ca2+ channels that cause the systolic
Ca2+ transient and subsequent myocardial
contraction[1,2]. There is a re-uptake of released
Ca2+ from the SR during contraction into the SR through SERCA2a. Given the dependence of the
SR Ca2+ content on the intracellular
Ca2+ concentration
([Ca2+]i), SERCA2a function, and spontaneous
Ca2+ release, the alteration of the SR
Ca2+ content may contribute to abnormal
intracellular Ca2+ handling, leading to myocardial dysfunction.
Previous studies have shown that hyperthyroidism
causes abnormalities in intracellular Ca2+ signaling com-ponents, which in turn results in cardiac hypertrophy and
arrhythmia[4,5]. For example, the enhanced
Ca2+ influx through the L-type
Ca2+ channel could partly account for the prolonged action potential duration and delayed
repolari-zation, and consequently aggravated arrhythmia
development during cardiac
hypertrophy[6]. The enhanced expression of functional RyR2, increased re-uptake of
Ca2+ into the SR through SERCA2a, and decreased phospholamban
expression have been reported after thyroxin injection,
which was suggested to be responsible, at least in part, for
the increase in the SR Ca2+ release and the
Ca2+ transient, as well as enhanced myocardial
contractility[4,7,8]. In the pressure-overload hypertrophy model, the SR
Ca2+ content decreased secondary to the reduced SERCA2a-mediated
Ca2+ uptake and increased sarcolemmal-mediated
Ca2+ efflux from the cell, which caused the smaller
Ca2+ transient and may contribute to the development of arrhythmias during
hypertrophy[9]. However, in the thyroxin-induced cardiac
hypertrophy model, the change in the SR
Ca2+ content and the underlying mechanism have still not been fully understood.
In this study, we used laser scanning confocal
microscopy and Ca2+-sensitive fluorescent indicators to examine
and quantitatively analyze the SR Ca2+ content, the
spontaneous Ca2+ sparks, and the basal
[Ca2+]i in quiescent cardiac
myocytes from normal rats and L-thyroxin-injected rats with
left ventricular hypertrophy (LVH). The lower SR
Ca2+ content was identified in this model. The
Ca2+ spark recording and analysis demonstrated the increase in the diastolic SR
Ca2+ leak, which may be due to more occurrences of
spontaneous Ca2+ sparks and an increase in the basal
[Ca2+]i. In addition, we observed the decreased activity of SERCA2a,
which may lead to the deteriorated function of SERCA2a,
contributing to the elevated
[Ca2+]i and lower SR
Ca2+ content in hypertrophied cardiac myocytes.
Materials and methods
L-thyroxin-induced cardiac
hypertrophy All experimental procedures were approved by the Sun Yat-Sen
University Committee for Animal Research (Guangzhou, China) and
were in accordance with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals. The L-thyroxin-induced cardiac hypertrophy model was prepared
as previously described[4]. Briefly, adult male
Sprague_Dawley rats (200±20 g, Experimental Animal Center, Sun
Yat-Sen University, China) were randomly divided into 2 groups.
The hyperthyroidism group (HT) was injected with L-thyroxin (1 mg/kg, intra-peritoneal) for 10 d to produce
hypertrophy. The normal-saline group (NS) was injected
with normal saline (controls). The Doppler echocardiographic
studies were performed at 10 d to assess the development of
heart hypertrophy.
Preparation of cardiac myocytes Single rat ventricular
myocytes were isolated from rats using a collagenase-based
enzymatic digestion technique[10]. Briefly, the animals were
anesthetized with sodium pentobarbital (50 mg/kg,
intra-peritoneal). The hearts were quickly removed and perfused
in a Langendorff mode. They were first perfused with
Ca2+-free Tyrode's solution composed of (in mmol/L) 136 NaOH,
5.4 KCl, 0.33 NaH2PO4, 1
MgCl2·6H2O, 10 HEPES, and 10
glucose (pH 7.4) at 37 °C for 10 min, then perfused with
Ca2+-free Tyrode's solution containing collagenase (type II, 0.5
mg/mL) for 15 min. The left and right ventricular tissues were
removed and myocytes were harvested. The isolated cells
were stored in a Krebs_bicarbonate solution containing (in
mmol/L) 50 K-glutamate, 20 KOH, 40 KCl, 20 taurine, 20
KH2PO4, 3
MgCl2·6H2O, 10 HEPES, 10 glucose, 0.5 ethylene
glycol tetraacetic acid (EGTA), and 1% bovine serum
albumin (pH 7.4) at room temperature. This procedure yields
50%_70% of Ca2+-tolerant, rod-shaped ventricular myocytes
with clear striations. Cells were used within 10 h after
isolation.
Line-scan imaging and Ca2+ spark analysis Myocytes were loaded with 4 µmol/L Fluo-3 AM (Molecular Probes,
Eugene, OR, USA) for 30 min at room temperature. The cells
were then placed on a Petri plate coated with poly-lysine and
were washed for 10 min to allow the de-esterification of the
indicator; quiescent myocytes with a typical rod-shaped form
and clear cross-striations were used for experiments. Fluo-3
was excited at 488 nm and the Ca2+ fluorescent signal was
acquired at 526 nm by confocal microscopy (FV500, Olympus,
Tokyo, Japan).
The [Ca2+]i in quiescent cells was reported as fluorescence
intensity (FI). To control the background FI, all parameters of
confocal microscopy were fixed when different samples were
measured. The SR Ca2+ content was assessed by the rapid
application of caffeine (20 mmol/L) in
Ca2+-free Tyrode's solution. The amplitude of the caffeine-induced
Ca2+ transient could be an index of the SR
Ca2+ load[11]. The
caffeine-induced Ca2+ transient was derived from changes in FI (F)
and normalized to basal fluorescence
(F0) and expressed as F/F0.
The spontaneous Ca2+ sparks were captured in
Ca2+(1.5 mmol/L)-containing Tyrode's solution over the entire cell
with the confocal microscope operating in x-t imaging mode.
The amplitude of spontaneous Ca2+ sparks
(F/F0, where F0 refers to the background of the Fluo-3/AM signal), duration
(full-duration-half-maximum [FDHM]), width, spatial size
(full-width-half-maximum [FWHM]), and
Ca2+spark frequency (CaSpF) were measured in a line-scan mode using a 60×
water immersion objective by an algorithm coded in IDL
5.4[12] and self-developed program with Matlab 6.5 (Mathworks,
Natick, MA, USA). All experiments were performed at room
temperature.
Preparation of SR membrane The SR was prepared as
previously described[13,14]. Briefly, the isolated ventricle was
frozen and homogenated in ice-cold homogenizing medium
containing (in mmol/L) 10 NaHCO3 and 5
NaN3, pH 7.0 using Polytron PT-20 (Brinkmann Instruments, Westbury,
NY, USA). The homogenate was centrifuged at 14
000×g for 20 min at 4 °C. The pellet was resuspended in 5
volumes of ice-cold buffer and centrifuged as before. The supernatant
from the second spin was sedimented at 45
000×g for 30 min and the pellet was resuspended in 25 mL of 0.6 mmol/L KCl
and 30 mmol/L histidine, pH 7.0, and centrifuged again. The
pellet consisting of the SR was resuspended in the solution
containing (in mmol/L) 30 histidine and 250 sucrose, pH 7.4,
and was stored at _80 °C.
Preparation of sarcolemma from rat hearts Sarcolemma was prepared from rat ventricles as per the kit manual
(Jiancheng, Nanjing, China). Briefly, the left and right
ventricles were minced in 9 volumes of ice-cold (0_4 °C)
homogenizing medium containing reagent I separately and filtrated
by double-deck gauze. The filtrate was sedimented at 10
750×g for 20 min, and the pellet obtained was washed twice
by reagent I. The pellet was then suspended with 10 mL
reagent II and placed at 0 ºC. After 48 h, the sediment was
centrifuged for 20 min at 10 750×g and then washed twice by
reagent III and preserved in reagent IV at 0 °C; the activity of
Ca2+-ATPase was measured within 48 h.
Measurement of Ca2+-ATPase activity The activity of Ca2+-ATPase was determined as per the kit manual
(Jiancheng, China) by measuring the inorganic phosphate
liberated from ATP hydrolysis[14]. Briefly,
Ca2+-ATPase activity was assayed in a medium containing (in mmol/L) 50
histidine, 3 MgCl2, 100 KCl, 5 sodium azide, 3 ATP, and 0.05
CaCl2, pH 7.0. The cardiac SR membrane was added to the
reaction mixture at a final concentration of 25 µg of
protein/mL, pre-incubated for 10 min at 37 °C, and the reaction was
initiated by the addition of ATP. The ATP hydrolysis that
occurred in the absence of Ca2+ (1 mmol/L EGTA) was
subtracted to determine the activity of
Ca2+-stimulated ATPase. Ouabain was added freshly to a final concentration of 1
mmol/L in the media, which remained unchanged throughout the
incubation. Mitochondrial contamination was excluded by
determining the activity of azide-sensitive
ATPase[15].
Statistics All data were expressed as mean±SEM. The
differences between the groups were analyzed by paired t-test or ANOVA, P<0.05 was considered significant.
Results
L-thyroxin injection created LVH All of the rats were
killed 10 d after the injection to examine the gross indexes of
hypertrophy. Compared with normal controls, the ratios of
heart weight to brain weight (HW/BW) and left ventricular
weight to BW (LVW/BW) in the HT group were increased
significantly by≈20% and ≈33%, respectively, whereas the
ratio of right ventricular weight to BW (RVW/BW) showed
no significant difference between the control and HT rats
(Table 1). Doppler echocardiography demonstrated that the
HT group had increased interventricular septum
end-diastolic thickness (IVSd) and interventricular septum
end-systolic thickness (IVSs; P<0.05; Table 1), but left ventricle
end-diastolic dimension (LVDd), left ventricle end-systolic
dimension (LVDs), end-diastolic posterior wall thickness
(PWd), and end-systolic posterior wall thickness (PWs) were
normal and similar in the HT and NS groups. Left systolic
ventricular function was assessed by ejection fraction (EF)
and left ventricular fractional shortening (LVFS); both
were not significantly different from the NS group (P>0.05; Table 1).The increased LVW/BW and preserved left ventricular
function in the HT group suggested that the exposure
to L-thyroxin produced compensated LVH.
SR Ca2+ content In the
Ca2+-free medium, the difference in the caffeine-induced
Ca2+ transient reflects the change in the SR
Ca2+ content. Figure 1A and 1B shows the
representative recordings of the Ca2+ transient upon the application
of 20 mmol/L caffeine in the left and right ventricular myocytes
from the NS and HT groups, Figure 1C compares the
amplitude of the caffeine-induced Ca2+ transient
(ΔF/F0) between different groups. In the left ventricular myocytes, the mean
values of ΔF/F0 in the HT group was significantly lower than
in the NS (0.42±0.06, n=21 vs 0.65±0.08, n=27; P<0.05). However, the regional difference in the SR
Ca2+ content was absent in right ventricular myocytes.
Spontaneous Ca2+ sparks Confocal microscopy was applied to directly quantify the
Ca2+ spark (Figure 2A,2B). The
Ca2+ spark is the basic Ca2+ release event from the SR, and it
is a local, discrete elevation in myoplasmic
[Ca2+]i due to the opening of the
RyR2[18]. Figure 2C_2F summarizes the
characteristics of spontaneous Ca2+ sparks in the NS and HT
groups. The CaSpF was higher in the HT animals than in the
NS animals (Figure 2C; 6.86±0.74 vs 2.89±0.32 sparks/s*100
µm; P<0.01). The mean amplitude of the
Ca2+ spark was lower in HT group than in NS group (Figure 2D;
2.84±0.28 vs 3.87±0.34, F/F0; P<0.01), consistent with the lower SR
Ca2+ content. The width and duration of the
Ca2+ sparks were not significantly changed in the HT group compared with those
in the NS group (Figure 2E,2F; FWHM: 1.4±0.15 vs 1.29±0.1 mm; FDHM: 25.7±2.14 vs 24.6±1.8 ms; P>0.05). The diastolic
SR Ca2+ leak was found to be related to the product
CaSpF×amplitude×FDHM×FWHM[16] , which was 1.5 times higher in the HT group than the NS group.
Because of the decreased SR content and increased
diastolic SR Ca2+ leak, we further compared the basal
[Ca2+]i between the NS and HT groups. The basal
[Ca2+]i was significantly elevated in quiescent left ventricular myocytes from
the HT group compared with that from the control
group (1432±153, n=38 vs 1143±144, n=32; P<0.05), whereas the basal
[Ca2+]i was unchanged in the right ventricle myocytes from
the hypertrophied heart (1110±123, n=40 vs 1150±130, n=63; P >0.05).
Ca2+-ATPase activity SERCA2a is the key
Ca2+-transport protein that re-uptakes
Ca2+ into the SR during relaxation. The activity of SERCA2a in left ventricular myocytes from
the HT group was significantly lower than in the NS group
(4.34±0.44 vs 6.15±0.41
µmol·h_1·mg_1 protein, n=6, P<0.01; Figure 3A), whereas there was no obvious change in the right
ventricle in both groups (n=6, P>0.05). The activity of
sarcolemmal Ca2+-ATPase in the hypertrophied left ventricle
decreased significantly compared with the NS
controls (1.49±0.12 vs 3.09±0.18
µmol·h_1·mg_1 protein, n=6, P<0.01; Figure 3B), whereas there was no obvious change in the right
ventricle (n=6, P>0.05).
Discussion
In the present study, it was demonstrated that the
ventricular myocytes from the L-thyroxin-induced hypertrophy
model decreased the caffeine-induced
Ca2+ transient in the Ca2+-free solution. The smaller caffeine-induced
Ca2+ transient could be explained by the lower SR
Ca 2+ content. We also observed the increased
Ca2+ leak, reduced SERCA activity, and increased basal
[Ca2+]i. in hypertrophied
ventricular myocytes in hyperthyroidism rats, which may be
involved in the possible mechanisms for the lower SR
Ca2+ content in ventricular myocytes in this hypertrophy model.
The SR Ca2+ content in cardiac cells reflects the balance
between Ca2+ release through RyR and
Ca2+ uptake into the SR via SERCA2a. The basic
Ca2+ release event was quantitatively detected and analyzed by a
Ca2+ spark recording and analysis. Since the SR
Ca2+ content mostly consists of the
Ca2+ transient (approximately 92%) leading to the initiation
of extracellular Ca2+ entry and subsequent myocardial
contraction in adult hearts[17], the decrease in the amplitude of
Ca2+ sparks indicates the lower SR
Ca2+ content.
Previous studies have shown the frequency of
Ca2+ sparks increases as the SR
Ca2+ load elevates, and the
smaller SR Ca2+ content is accompanied by fewer
Ca2+ spark rates[18,19].
However, we observed a higher
Ca2+ spark frequency with a decrease
in SR Ca2+ content in this hypertrophy model. The
paradoxical observation was also found in a severe but
compensated canine LVH model, where the
hyperphosphorylation of RyR2 was demonstrated to cause pathological
hypersensitivity of RyR2 and release more Ca2+ in the diastolic period, leading to an increased occurrence of
Ca2+ spark frequency[3]. In the same L-thyroxin-induced hypertrophy model, the increased expression of RyR2 has been reported
in the hypertrophied heart tissue[4,7]. Therefore, more RyR2
in the SR and/or its hypersensitivity may be able to evoke
more Ca2+ sparks. Another possibility for increased
occurrences of spontaneous Ca2+ sparks may be due to the firing
of Ca2+ release from some
"Ca2+-overloaded" subcellular
regions in hypertrophied myocytes[3]. However, this
possibility requires further examination in the L-thyroxin induced hypertrophy model.
The spontaneous Ca2+ leak occurs as the loss of
Ca2+ from the SR under resting conditions, which also plays a
role in the diastolic removal of Ca2+ from the SR
Ca2+ content[20]. The enhanced SR
Ca2+ leak was reported in the hypertrophy model induced by the
Calcium/calmodulin-dependent protein kinase type II delta
(CaMKIIδ) overexpression[16]. This model also points out that the enhanced
expression of RyR2 with hypersensitivity may contribute to the
increased SR Ca2+ leak. The increased
Ca2+ leak and higher basal
[Ca2+]i that we observed in the present study may
therefore explain the arrhythmogenesis in the hyperthyroid heart.
In addition, the SR Ca2+ release channels are activated as
[Ca2+]i elevates. Therefore, the increased
Ca2+ spark frequency during hypertrophy may also be secondary to an increase in
[Ca2+]i.
The size of the SR Ca2+ content is dependent on the
Ca2+ re-uptake through SERCA2a. The smaller SR
Ca2+ content may be associated with reduced SERCA2a function. In the L-thyroxin-induced cardiac hypertrophy model, enhanced
RyR2 and the SERCA2a mRNA level was observed and was
associated with Ca2+ overload contributing to
arrhythmogenesis during hypertrophy[4]. The expression of SERCA2a RNA
and protein has been observed in hypertrophy
models[4,21], but whether the activity of SERCA2a was altered had not
previously been examined. In the present study, we
observed a marked decrease in the activity of SERCA2a in the
hypertrophied heart, which seemed to result in decreased
SERCA2a function and may have contributed to the
decreased SR Ca2+ content and increased basal
[Ca2+]i. However, another possibility could not be excluded. The
augmented expression level with the decreased activity of
SERCA2a may not only cause more Ca2+ re-uptake back into
Ca2+ store, but also cause oxygen wastage, which is
consistent with increased oxygen consumption in the
hyperthyroid heart.
In addition, there is controversy over whether there is
change in the SERCA2a expression in the hyperthyroid heart.
Takeuchi et al reported that there was no change in the
SERCA2a protein expression in the hyperthyroid heart and
proposed that the SERCA2a activity would be enhanced to
lead to metabolic derangement[22], but they did not examine
the SERCA2a activity in their study. It should be noted that
the activity of ATPase
(Na+/K+-ATPase and
K+/Ca2+-ATPase) at the sarcolemma, SR, and mitochondria might be
differently modified in the process of
hypertrophy[23]. Because we facilitated the procedure to examine the activity of
ATPase in subcelluar populations enriched in the SR and
sarcolemma, respectively, the possible contamination from
mitochondria was excluded. Although we did not further
examine how SERCA2a function is altered and how
myocardial contraction changes, the present study raises decreased
SERCA2a activity as a potential mechanism for decreased
SR Ca2+ content.
In the present study, we found that the elevated basal
[Ca2+]i could be due to the increased
Ca2+ leak and reduced SERCA2a activity. In diastolic
Ca2+ removal from the cytosol in the rat heart, the contribution of SERCA2a has been
demonstrated to be predominant than that of the
Na+_Ca2+ exchange[24]. However, it is noteworthy that acute exposure
to the thyroid hormone stimulated the activity of reverse
mode Na+_Ca2+ exchange in cat atrial myocytes and
increased [Ca2+]i, which was suggested to be involved in
Ca2+-mediated arrhythmic
activity[25]. Because this mode of
Ca2+ influx may also account for the increased basal
[Ca2+]i in the hyperthyroid
ventricle[25], the role of
Na+_Ca2+ exchange in rat hypertrophied ventricular myocytes needs further
investigation.
In summary, the results of our present study suggest
that the increased Ca2+ leak and reduced SERCA2a activity
may contribute to decreased SR Ca2+ content and increased
basal [Ca2+]i in ventricular myocytes in the L-thyroxin-induced hypertrophy model.
Acknowledgments
We thank Prof Jian-xin SHEN (Department of Physiology,
University of Shan Tou) and Yan-qiu FENG (Department of
Biomedical Engineering, The Southern Medical University)
for their help with the Ca2+ spark recording.
References
1 Guatimosim S, Dilly K, Santana LF, Saleet Jafri M, Sobie EA,
Lederer WJ. Local Ca2+ signaling and EC coupling in heart:
Ca(2+) sparks and the regulation of the
[Ca2+]i transient. J Mol Cell
Cardiol 2002; 34: 941_50.
2 Balke CW, Shorofsky SR. Alterations in calcium handling in
cardiac hypertrophy and heart failure. Cardiovasc Res 1998; 37:
290_9.
3 Song LS, Pi Y, Kim SJ, Yatani A, Guatimosim S, Kudej RK, et al. Paradoxical cellular
Ca2+ signaling in severe but compensated
canine left ventricular hypertrophy. Circ Res 2005; 97: 457_64.
4 Wu XD, Dai DZ, Zhang QP, Gao F. Propranolol and verapamil
inhibit mRNA expression of RyR2 and SERCA in L-thyroxin-induced rat ventricular hypertrophy. Acta Pharmacol Sin 2004;
25: 347_51.
5 Dillmann WH. Cellular action of thyroid hormone on the heart.
Thyroid 2002; 12: 447_52.
6 Dai DZ, Hu HJ, Yang DM, Hao XM, Zhang GQ, Zhou PA, et al. Chronic levothyroxin treatment is associated with ion channel
abnormalities in cardiac and neuronal cells. Clin Exp Pharmacol
Physiol 1999; 26: 819_21.
7 Jiang M, Xu A, Tokmakejian S, Narayanan N. Thyroid
hormone-induced overexpression of functional ryanodine receptors
in the rabbit heart. Am J Physiol Heart Circ Physiol 2000; 278:
H1429_38.
8 Shenoy R, Klein I, Ojamaa K. Differential regulation of SR
calcium transporters by thyroid hormone in rat atria and ventricles.
Am J Physiol Heart Circ Physiol 2001; 281: H1690_6.
9 Diaz ME, Graham HK, Trafford AW. Enhanced sarcolemmal
Ca2+ efflux reduces sarcoplasmic reticulum
Ca2+ content and systolic
Ca2+ in cardiac hypertrophy. Cardiovasc Res 2004; 62:
538_47.
10 Xiao RP, Ji X, Lakatta EG. Functional coupling of the beta
2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac
myocytes. Mol Pharmacol 1995; 47: 322_9.
11 Negretti N, O'Neill SC, Eisner DA. The relative contributions of
different intracellular and sarcolemmal systems to relaxation in
rat ventricular myocytes. Cardiovasc Res 1993; 27: 1826_30.
12 Cheng H, Song LS, Shirokova N, Gonzalez A, Lakatta EG, Rios
E, et al. Amplitude distribution of calcium sparks in confocal
images: theory and studies with an automatic detection method.
Biophys J 1999; 76: 606_17.
13 Jones LR, Besch HR Jr, Fleming JW, McConnaughey MM,
Watanabe AM. Separation of vesicles of cardiac sarcolemma
from vesicles of cardiac sarcoplasmic reticulum. Comparative
biochemical analysis of component activities. J Biol Chem 1979;
254: 530_9.
14 Kodavanti PR, Cameron JA, Yallapragada PR, Desaiah D. Effect of
chlordecone (Kepone) on calcium transport mechanisms in rat heart
sarcoplasmic reticulum. Pharmacol Toxicol 1990; 67: 227_34.
15 Lindemann JP, Jones LR, Hathaway DR, Henry BG, Watanabe
AM. α-Adrenergic stimulation of phospholamban
phosphorylation and Ca2+-ATPase activity in guinea pig ventricles. J Biol
Chem 1983; 258: 464_71.
16 Maier LS, Zhang T, Chen L, DeSantiago J, Brown JH, Bers DM.
Transgenic CaMKIIdeltaC overexpression uniquely alters
cardiac myocyte Ca2+ handling: reduced SR
Ca2+ load and activated SR
Ca2+ release. Circ Res 2003; 92: 904_11.
17 Delbridge LM, Satoh H, Yuan W, Bassani JW, Qi M, Ginsburg KS, et al. Cardiac myocyte volume,
Ca2+ fluxes, and sarcoplasmic reticulum loading in pressure-overload hypertrophy. Am J Physiol
1997; 272: H2425_35.
18 Cheng H, Lederer WJ, Cannell MB. Calcium sparks: elementary
events underlying excitation-contraction coupling in heart muscle.
Science 1993; 262: 740_44.
19 Santana LF, Cheng H, Gomez AM, Cannell MB, Lederer WJ.
Relation between the sarcolemmal Ca2+ current and
Ca2+ sparks and local control theories for cardiac excitation-contraction
coupling. Circ Res 1996; 78: 166_71.
20 Sobie EA, Guatimosim S, Gomez-Viquez L, Song LS, Hartmann
H, Saleet Jafri M, et al. The
Ca2+ leak paradox and rogue ryanodine
receptors: SR Ca2+ efflux theory and practice. Prog Biophys Mol
Biol 2006; 90: 172_85.
21 Kim YK, Kim SJ, Yatani A, Huang Y, Castelli G, Vatner DE, et al. Mechanism of enhanced cardiac function in mice with hypertrophy
induced by overexpressed Akt. J Biol Chem.2003; 278: 47 622_8.
22 Takeuchi K, Minakawa M, Otaki M, Odagiri S, Itoh K, Murakami
A, et al. Hyperthyroidism causes mechanical insufficiency of
myocardium with possibly increased SR
Ca2+-ATPase activity. Jpn J Physiol 2003; 53: 411_6.
23 Moisin C, Balta N, Filcescu V, Dumitriu IF, Stoian G, Petec G.
Activity of Na+/K+-ATPase and of Ca++-ATPase under the
action of adenosine triphosphate in experimental myocardial
hypertrophy. Rom J Physiol 1998; 35: 303_11.
24 Bassani JW, Bassani RA, Bers DM. Relaxation in rabbit and rat
cardiac cells: species-dependent differences in cellular mechanisms.
J Physiol 1994; 476: 279_93.
25 Wang HL, Dai DZ, Gao E, Zhang YP, Lu F. Dispersion of
ventricular mRNA of RyR2 and SERCA2 associated with
arrhythmogenesis in rats. Acta Pharmacol Sin 2004; 25: 738_43.
|